Trials / Completed
CompletedNCT05173194
Remotely Supervised Exercise for Adults With Cystic Fibrosis
Effects of a Remotely Supervised Exercise Program on Inflammatory Markers, Muscle Strength and Lung Function in Adult Patients With Cystic Fibrosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Universidad Europea de Madrid · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Cystic fibrosis (CF) is a genetic disease characterized by abnormal chloride transport in epithelial tissues. Inflammation is a key component contributing to the main alterations induced by the disease. The increase in life expectancy comes with a higher prevalence of CF-related comorbidities, but also with new emerging complications directly related to aging. Physical fitness and exercise practice have been previously associated to survival and better quality of life in patients with cystic fibrosis. Thus, the aim of this study is to assess the effects of a remotely supervised resistance exercise program on lung function, muscle strength, body composition, quality of life and inflammatory markers in adult patients with cystic fibrosis.
Detailed description
This study aims to assess the effects of a remotely supervised resistance exercise program on lung function, muscle strength, body composition, quality of life and inflammatory markers in adult patients with cystic fibrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise | Eight-week program of a remotely supervised resistance exercise. Frequency: three times per week. Duration: 60 minutes per session. Training program: warm-up and joint mobility; strength exercises for different muscle groups; and cool down (stretching and breathing exercises). |
Timeline
- Start date
- 2021-10-26
- Primary completion
- 2021-12-30
- Completion
- 2021-12-30
- First posted
- 2021-12-29
- Last updated
- 2023-12-05
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05173194. Inclusion in this directory is not an endorsement.